IN8BIO, INC Share Price Today: Live Updates & Key Insights
IN8BIO, INC share price today is $2.04, up 16.28%. The stock opened at $1.7 against the previous close of $1.72, with an intraday high of $2.01 and low of $1.7.
IN8BIO, INC Share Price Chart
IN8BIO, INC
IN8BIO, INC Share Price Performance
IN8BIO, INC Institutional Holdings
IN8BIO, INC Market Status
IN8BIO, INC Fundamentals
Market Cap 19.69 M
PB Ratio 0.6095
PE Ratio 0.0
Enterprise Value -5.06 M
Total Assets 32.28 M
Volume 254382
IN8BIO, INC Company Financials
About IN8BIO, INC & investment objective
Company Information IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer; and INB-600, a gamma-Delta T cell engager. In addition, it is developing INB-619, a gamma-delta TCE targeting CD19 for potential applications in both oncology and autoimmune diseases. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Organisation Biotechnology
Employees 17
Industry Biotechnology
CEO Mr. Tai-Wei Ho
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
IN8BIO, INC FAQs
What is the share price of IN8BIO, INC today?
The current share price of IN8BIO, INC is $2.04.
Can I buy IN8BIO, INC shares in India?
Yes, Indian investors can buy IN8BIO, INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy IN8BIO, INC shares in India?
You can easily invest in IN8BIO, INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy IN8BIO, INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of IN8BIO, INC.
Can I buy fractional shares of IN8BIO, INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of IN8BIO, INC?
IN8BIO, INC has a market cap of $19.69 M.
In which sector does IN8BIO, INC belong?
IN8BIO, INC operates in the Biotechnology sector.
What documents are required to invest in IN8BIO, INC stocks?
To invest, you typically need:
What is the PE and PB ratio of IN8BIO, INC?
The PE ratio of IN8BIO, INC is N/A and the PB ratio is 0.61.